Your session is about to expire
← Back to Search
Lidocaine + Ketamine vs Paravertebral Block for Rib Fractures
Study Summary
This trial is testing whether using a lidocaine and ketamine infusion to control pain from rib fractures is non-inferior to the current standard of care, which is to begin with acetaminophen, ibuprofen or celecoxib and opioids with the addition of paravertebral blocks as needed.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had or am expected to have brain surgery during this hospital stay.I need help with daily activities like eating, dressing, or bathing.I have had or will have chest surgery during this hospital stay.I have had or will need surgery for a pelvic injury.I was on a breathing machine when I was admitted to the hospital.You are currently in jail or prison.I am over 80 years old.I am expected to or have had exploratory surgery in my abdomen during this hospital stay.I am between 18 and 80 years old and hospitalized due to a broken rib.My consciousness level is moderately impaired.I have a spinal cord injury.My usual pain management isn't working, and I have severe breathing issues and a weak cough.I am under 18 years old.
- Group 1: lidocaine/ ketamine infusion
- Group 2: paravertebral block with ropivacaine
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research endeavor still enrolling participants?
"According to clinicaltrials.gov, this medical study commenced recruitment on September 1st 2020 and is still in need of patients with the most recent edit occurring on April 27th 2022."
Have any prior studies been conducted regarding lidocaine/ ketamine infusions?
"Presently, 273 studies are investigating the efficacy of lidocaine/ ketamine infusion. Of those trials, 61 have progressed to Phase 3 evaluations. While most investigations are based in Duarte, California, 1323 sites worldwide offer this treatment trial as an option for their patients."
What are the typical applications for lidocaine/ ketamine infusions?
"Lidocaine/ ketamine infusion can be utilized to address cervical syndrome, minor burns, and general anesthesia."
What is the uppermost limit of individuals enrolled in this experiment?
"Affirmative, the information on clinicaltrials.gov indicates that this medical research is currently recruiting individuals. It was initially posted in September of 2020 and has been recently modified in April 2022; 170 participants are desired from a single site."
What are the fundamental goals of this clinical experiment?
"The primary purpose of this trial, which will be monitored over the span of a typical inpatient hospital stay (one week), is to measure Oral Morphine Equivalence (OME). Secondary objectives include assessing the incidence of pneumonia via diagnosis by attending medical personnel, tracking patient disposition after discharge such as home care or long-term acute facility stays, and monitoring in-hospital mortality."
Is this medical experiment open to minors?
"To be eligible for this medical study, applicants must between 18 and 80 years old. There are 118 trials specifically targeting minors and 614 aimed at individuals over the age of 65."
Are my qualifications sufficient to join this experimental undertaking?
"This research is seeking 170 qualified volunteers between 18 and 80 of age, with rib fractures causing acute pain. Furthermore, potential participants must have been admitted to a hospital for treatment related to their injury."
Share this study with friends
Copy Link
Messenger